Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

This study has been terminated.
(Study is now terminated due to technical difficulties with administration of study drug in this patient population with this schedule)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00497679
First received: July 5, 2007
Last updated: May 13, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given